$75.54
-2.44-3.13%
At Close: -
$77.30
1.762.33%
After Hours: 6:46 PM EDT
15 minutes delayed
Comments
Loading...
Insmed
INSMNASDAQ
Insmed (NASDAQ:INSM) Stock, Insider Trading Activity
Insmed: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Insmed Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On May 17, 2024, Martina Flammer M.D,, the company's CHIEF MEDICAL OFFICER sold 4.64K shares for $25.09 each.
- On May 17, 2024, Roger Adsett, the company's CHIEF OPERATING OFFICER sold 5.95K shares for $25.09 each.
- On May 30, 2024, John Drayton Wise, the company's CHIEF COMMERCIAL OFFICER sold 1.6K shares for $31.18 each.
Ownership Statistics for Insmed Inc
Institutional Shares Held
121.102M
Institutional Percentage Held
74.2%
| Jun 12, 2024 | Martina Flammer M.D., | CHIEF MEDICAL OFFICER | 0.00 | $41.88 | -$768.32K | SELL-OPTIONS | 0.00% | 106.13K | Jun 10 | View |
| Jun 05, 2024 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $38.21 | -$1.88M | SELL-OPTIONS | 0.00% | 108.76K | Jun 03 | View |
| May 30, 2024 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | -1.60K | $31.18 | -$312.29K | SELL | -1.30% | 121.66K | May 28 | View |
| May 30, 2024 | Michael A. Smith | CHIEF LEGAL OFFICER | -5.75K | $31.90 | -$1.66M | SELL | -6.08% | 88.83K | May 28 | View |
| May 30, 2024 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $31.05 | -$1.02M | SELL-OPTIONS | 0.00% | 108.76K | May 28 | View |
| May 30, 2024 | Martina Flammer M.D., | CHIEF MEDICAL OFFICER | 0.00 | $37.10 | -$3.36M | SELL-OPTIONS | 0.00% | 106.13K | May 28 - May 30 | View |
| May 30, 2024 | Sara Bonstein | CHIEF FINANCIAL OFFICER | 0.00 | $38.27 | -$5.66M | SELL-OPTIONS | 0.00% | 117.48K | May 28 - May 29 | View |
| May 17, 2024 | Martina Flammer M.D, | CHIEF MEDICAL OFFICER | -4.64K | $25.09 | -$116.47K | SELL | -4.19% | 106.13K | May 17 | View |
| May 17, 2024 | Roger Adsett | CHIEF OPERATING OFFICER | -5.95K | $25.09 | -$149.16K | SELL | -3.83% | 149.28K | May 17 | View |
| May 15, 2024 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | 9.43K | $25.47 | -$129.59K | GRANT | 8.28% | 123.26K | May 13 - May 14 | View |
| May 15, 2024 | Michael A. Smith | CHIEF LEGAL OFFICER | 8.21K | $25.40 | -$129.36K | GRANT | 9.51% | 94.58K | May 13 - May 14 | View |
| May 15, 2024 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | 6.80K | $25.53 | -$166.15K | GRANT | 6.67% | 108.76K | May 13 - May 14 | View |
| May 15, 2024 | William Lewis | CHAIR AND CEO | 20.51K | $25.52 | -$566.49K | GRANT | 4.95% | 434.63K | May 13 - May 14 | View |
| May 15, 2024 | Martina Flammer M.D, | CHIEF MEDICAL OFFICER | 3.88K | $25.47 | -$271.00K | GRANT | 3.63% | 110.78K | May 13 - May 14 | View |
| May 15, 2024 | Sara Bonstein | CHIEF FINANCIAL OFFICER | 3.43K | $25.32 | -$280.75K | GRANT | 3.01% | 117.48K | May 13 - May 14 | View |
| May 15, 2024 | Roger Adsett | CHIEF OPERATING OFFICER | 6.66K | $25.50 | -$200.35K | GRANT | 4.48% | 155.22K | May 13 - May 14 | View |
| Jan 12, 2024 | Martina Flammer M.D.by Michael A. Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | -4.67K | $28.63 | -$133.62K | SELL | -4.18% | 106.90K | Jan 12 | View |
| Jan 12, 2024 | Roger Adsett | CHIEF OPERATING OFFICER | -5.25K | $28.63 | -$150.34K | SELL | -3.41% | 148.56K | Jan 12 | View |
| Jan 11, 2024 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | -1.86K | $28.78 | -$53.56K | SELL | -1.61% | 113.83K | Jan 09 | View |
| Jan 11, 2024 | Michael A. Smith | GENERAL COUNSEL, SENIOR VP | -2.37K | $28.76 | -$68.25K | SELL | -2.67% | 86.36K | Jan 09 | View |
| Jan 11, 2024 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | -3.17K | $24.67 | -$95.52K | SELL | -3.01% | 101.98K | Jan 09 | View |
| Jan 11, 2024 | Martina Flammer M.D.by Michael A. Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | -5.96K | $28.99 | -$172.76K | SELL | -5.07% | 111.56K | Jan 09 - Jan 10 | View |
| Jan 11, 2024 | Sara Bonstein | CHIEF FINANCIAL OFFICER | -4.50K | $29.18 | -$131.22K | SELL | -3.79% | 114.05K | Jan 09 | View |
| Jan 11, 2024 | Roger Adsett | CHIEF OPERATING OFFICER | -7.37K | $29.08 | -$214.42K | SELL | -4.57% | 153.81K | Jan 09 - Jan 10 | View |
| Jan 10, 2024 | William Lewis | CHAIR AND CEO | -9.89K | $24.91 | -$688.42K | SELL | -2.64% | 364.15K | Jan 08 - Jan 09 | View |
| Jan 05, 2024 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | 11.71K | $24.15 | -$236.53K | SELL-OPTIONS | 11.26% | 115.69K | Jan 03 - Jan 05 | View |
| Jan 05, 2024 | Michael A. Smith | GENERAL COUNSEL, SENIOR VP | 11.17K | $29.30 | -$18.37K | GRANT | 14.40% | 88.74K | Jan 04 - Jan 05 | View |
| Jan 05, 2024 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | 10.34K | $29.28 | -$42.66K | GRANT | 10.91% | 105.15K | Jan 04 - Jan 05 | View |
| Jan 05, 2024 | William Lewis | CHAIR AND CEO | 30.89K | $29.26 | -$204.20K | GRANT | 9.00% | 374.04K | Jan 04 - Jan 05 | View |
| Jan 05, 2024 | Martina Flammer M.D.by Michael A. Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | 11.49K | $29.20 | -$40.48K | GRANT | 10.83% | 117.53K | Jan 04 - Jan 05 | View |
| Jan 05, 2024 | Roger Adsett | CHIEF OPERATING OFFICER | 9.83K | $29.21 | -$88.86K | GRANT | 6.50% | 161.18K | Jan 04 - Jan 05 | View |
| Jan 02, 2024 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $26.24 | -$256.53K | SELL-OPTIONS | 0.00% | 94.55K | Dec 28 | View |
| Dec 22, 2023 | Martina Flammer M.D.by Michael A. Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | 0.00 | $26.83 | -$179.49K | SELL-OPTIONS | 0.00% | 106.04K | Dec 22 | View |
| Dec 22, 2023 | Sara Bonstein | CHIEF FINANCIAL OFFICER | -13.20K | $30.00 | -$395.97K | SELL | -11.14% | 105.24K | Dec 22 | View |
| Oct 31, 2023 | William Lewis | CHAIR AND CEO | 500.00 | $19.16 | -$1.09M | SELL-OPTIONS | 0.09% | 576.57K | Oct 27 | View |
| Jul 13, 2023 | Michael A. Smith | GENERAL COUNSEL, SENIOR VP | -740.00 | $20.18 | -$14.93K | SELL | -0.95% | 77.14K | Jul 11 | View |
| Jun 15, 2023 | Martina Flammer M.D.by Michael A. Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | -8.87K | $19.27 | -$170.89K | SELL | -7.72% | 106.04K | Jun 13 | View |
| Jun 15, 2023 | Roger Adsett | CHIEF OPERATING OFFICER | -8.98K | $19.32 | -$173.51K | SELL | -5.60% | 151.35K | Jun 13 | View |
| May 26, 2023 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | -3.37K | $18.95 | -$63.79K | SELL | -3.17% | 102.68K | May 25 | View |
| May 17, 2023 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | -2.89K | $18.44 | -$53.22K | SELL | -2.65% | 106.05K | May 15 - May 17 | View |
| May 17, 2023 | Michael A. Smith | GENERAL COUNSEL, SENIOR VP | -3.63K | $18.77 | -$68.21K | SELL | -4.50% | 77.08K | May 15 - May 17 | View |
| May 17, 2023 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | -5.02K | $18.62 | -$93.44K | SELL | -5.09% | 93.53K | May 15 - May 17 | View |
| May 17, 2023 | William Lewis | CHAIR AND CEO | -16.86K | $18.58 | -$313.31K | SELL | -2.85% | 575.27K | May 15 - May 17 | View |
| May 17, 2023 | Martina Flammer M.D.by Michael A. Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | -4.29K | $18.94 | -$81.33K | SELL | -3.60% | 114.91K | May 15 - May 16 | View |
| May 17, 2023 | Sara Bonstein | CHIEF FINANCIAL OFFICER | -3.82K | $18.95 | -$72.39K | SELL | -3.15% | 117.62K | May 15 - May 16 | View |
| May 17, 2023 | Roger Adsett | CHIEF OPERATING OFFICER | -6.82K | $18.66 | -$127.19K | SELL | -4.08% | 160.33K | May 15 - May 17 | View |
| May 17, 2023 | Melvin Sharoky M.D., | DIRECTOR | 20.00K | $19.29 | $385.80K | BUY | ∞ | 11.85K | May 15 | View |
| Jan 12, 2023 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | -779.00 | $17.96 | -$13.99K | SELL | -1.00% | 77.27K | Jan 10 | View |
| Jan 12, 2023 | Michael Smith | GENERAL COUNSEL, SENIOR VP | -1.84K | $17.93 | -$32.92K | SELL | -3.27% | 54.33K | Jan 10 | View |
| Jan 12, 2023 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | -2.44K | $17.95 | -$43.71K | SELL | -3.26% | 72.16K | Jan 10 | View |
| Jan 12, 2023 | William Lewis | CHAIR AND CEO | -6.99K | $18.00 | -$125.89K | SELL | -2.57% | 265.07K | Jan 10 | View |
| Jan 12, 2023 | Martina Flammer M.D.by Michael Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | -3.44K | $18.06 | -$62.11K | SELL | -4.51% | 72.76K | Jan 10 | View |
| Jan 12, 2023 | Sara Bonstein | CHIEF FINANCIAL OFFICER | -2.86K | $18.12 | -$51.77K | SELL | -4.15% | 66.03K | Jan 10 | View |
| Jan 12, 2023 | Roger Adsett | CHIEF OPERATING OFFICER | -3.19K | $17.99 | -$57.46K | SELL | -2.30% | 135.49K | Jan 10 | View |
| Jan 06, 2023 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | 6.44K | $19.74 | -$22.90K | GRANT | 8.99% | 78.05K | Jan 05 | View |
| Jan 06, 2023 | Michael Smith | GENERAL COUNSEL, SENIOR VP | 5.61K | $19.72 | -$14.20K | GRANT | 11.10% | 56.17K | Jan 05 | View |
| Jan 06, 2023 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | 4.88K | $19.73 | -$28.57K | GRANT | 7.01% | 74.59K | Jan 05 | View |
| Jan 06, 2023 | William Lewis | CHAIR AND CEO | 15.35K | $19.80 | -$138.76K | GRANT | 5.98% | 272.06K | Jan 05 | View |
| Jan 06, 2023 | Martina Flammer M.D.by Michael Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | 9.77K | $19.73 | -$27.11K | GRANT | 14.71% | 76.20K | Jan 05 | View |
| Jan 06, 2023 | Roger Adsett | CHIEF OPERATING OFFICER | 4.55K | $19.75 | -$60.12K | GRANT | 3.40% | 138.68K | Jan 05 | View |
| Nov 22, 2022 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | -7.15K | $18.84 | -$134.78K | SELL | -9.08% | 71.61K | Nov 22 | View |
| Nov 22, 2022 | Roger Adsett | CHIEF OPERATING OFFICER | -11.86K | $18.80 | -$222.87K | SELL | -8.12% | 134.13K | Nov 22 | View |
| Nov 02, 2022 | Melvin Sharoky M.D, | DIRECTOR | 30.00K | $17.59 | $527.60K | BUY | ∞ | 17.50K | Oct 31 - Nov 01 | View |
| Nov 02, 2022 | Leo Lee | DIRECTOR | 45.00K | $17.69 | $796.05K | BUY | 84.48% | 98.27K | Oct 31 | View |
| Aug 12, 2022 | John Drayton Wise | CHIEF COMMERCIAL OFFICER | -258.00 | $27.79 | -$7.17K | SELL | -0.33% | 78.77K | Aug 10 | View |
| Aug 10, 2022 | William Lewis | CHAIR AND CEO | 0.00 | $16.11 | -$5.08M | SELL-OPTIONS | 0.00% | 256.72K | Aug 08 | View |
| Jul 12, 2022 | Michael Smith | GENERAL COUNSEL, SENIOR VP | -941.00 | $23.40 | -$22.02K | SELL | -1.83% | 50.45K | Jul 12 | View |
| Jul 08, 2022 | William Lewis | CHAIR AND CEO | 0.00 | $19.58 | -$660.84K | SELL-OPTIONS | 0.00% | 256.72K | Jul 07 | View |
| May 18, 2022 | Roger Adsett | CHIEF OPERATING OFFICER | -3.42K | $19.57 | -$66.85K | SELL | -2.29% | 145.98K | May 16 - May 17 | View |
| May 18, 2022 | Sara Bonstein | CHIEF FINANCIAL OFFICER | -1.43K | $18.51 | -$26.52K | SELL | -2.55% | 54.68K | May 16 | View |
| May 18, 2022 | Martina Flammer M.D. | CHIEF MEDICAL OFFICER | -1.57K | $18.51 | -$29.13K | SELL | -2.31% | 66.43K | May 16 | View |
| May 18, 2022 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | -2.78K | $19.53 | -$54.36K | SELL | -3.89% | 68.82K | May 16 - May 17 | View |
| May 18, 2022 | Michael Smith | GENERAL COUNSEL, SENIOR VP | -1.49K | $19.82 | -$29.49K | SELL | -2.86% | 50.58K | May 16 - May 17 | View |
| May 18, 2022 | William Lewis | CHAIR AND CEO | -9.39K | $19.52 | -$183.35K | SELL | -3.54% | 255.83K | May 16 - May 17 | View |
| May 13, 2022 | Melvin Sharoky M.D, | — | 34.65K | $17.20 | $344.00K | BUY | 15.12% | 263.81K | May 11 | View |
| Mar 25, 2022 | William Lewis | CHAIR AND CEO | 0.00 | $19.36 | -$734.78K | SELL-OPTIONS | 0.00% | 217.62K | Mar 23 | View |
| Jan 13, 2022 | William Lewis | CHAIR AND CEO | -2.87K | $25.11 | -$72.14K | SELL | -1.30% | 217.62K | Jan 11 | View |
| Jan 13, 2022 | Michael Smith | GENERAL COUNSEL, SENIOR VP | -407.00 | $25.11 | -$10.22K | SELL | -1.08% | 37.43K | Jan 11 | View |
| Jan 13, 2022 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | -925.00 | $25.11 | -$23.23K | SELL | -1.60% | 56.96K | Jan 11 | View |
| Jan 13, 2022 | Roger Adsett | CHIEF OPERATING OFFICER | -1.22K | $24.58 | -$29.91K | SELL | -0.99% | 121.94K | Jan 12 | View |
| Jan 13, 2022 | Martina Flammer M.D.by Michael Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | -1.50K | $25.11 | -$37.54K | SELL | -3.15% | 46.04K | Jan 11 | View |
| Jan 13, 2022 | Sara Bonstein | CHIEF FINANCIAL OFFICER | -1.15K | $25.11 | -$28.98K | SELL | -3.11% | 35.98K | Jan 11 | View |
| Jan 07, 2022 | Roger Adsett | CHIEF OPERATING OFFICER | -4.83K | $27.02 | -$130.44K | SELL | -4.38% | 105.42K | Jan 05 - Jan 06 | View |
| Jan 07, 2022 | William Lewis | CHAIR AND CEO | -12.46K | $26.92 | -$335.51K | SELL | -6.16% | 189.76K | Jan 05 - Jan 06 | View |
| Jan 07, 2022 | Martina Flammer M.D.by Michael Smith as Attorney in Fact | CHIEF MEDICAL OFFICER | -1.42K | $27.61 | -$39.29K | SELL | -4.09% | 33.34K | Jan 05 | View |
| Jan 07, 2022 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | -3.12K | $26.78 | -$83.41K | SELL | -6.04% | 48.43K | Jan 05 - Jan 06 | View |
| Jan 07, 2022 | Michael Alexander Smith | GENERAL COUNSEL, SENIOR VP | -1.14K | $27.06 | -$30.74K | SELL | -3.85% | 28.38K | Jan 05 - Jan 06 | View |
| Dec 28, 2021 | William Lewis | CHAIR AND CEO | 0.00 | $20.92 | -$1.36M | SELL-OPTIONS | 0.00% | 202.22K | Dec 23 - Dec 27 | View |
| Nov 03, 2021 | S. Nicole Schaeffer | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $21.36 | -$1.09M | SELL-OPTIONS | 0.00% | 51.51K | Nov 01 | View |
| Nov 03, 2021 | David Brennan | — | 10.00K | $30.15 | $301.50K | BUY | 14.11% | 80.88K | Nov 01 | View |
| Nov 03, 2021 | Steinar Engelsen M.D., | — | 14.23K | $30.14 | $429.04K | BUY | 4.64% | 320.80K | Nov 01 | View |
| Oct 01, 2021 | William Lewis | CHAIR AND CEO | 0.00 | $15.38 | -$2.32M | SELL-OPTIONS | 0.00% | 202.22K | Sep 30 | View |
| Sep 09, 2021 | John Soriano | CHIEF COMPLIANCE OFFICER | 0.00 | $21.05 | -$247.92K | SELL-OPTIONS | 0.00% | 35.20K | Sep 07 | View |
| Mar 18, 2021 | William Lewis | CHAIR AND CEO | 0.00 | $19.79 | -$1.64M | SELL-OPTIONS | 0.00% | 179.61K | Mar 16 | View |
| Mar 12, 2021 | John Soriano | CHIEF COMPLIANCE OFFICER | 0.00 | $35.43 | -$216.77K | SELL-OPTIONS | 0.00% | 29.77K | Mar 11 | View |
| Mar 11, 2021 | John Soriano | CHIEF COMPLIANCE OFFICER | 0.00 | $31.27 | -$826.66K | SELL-OPTIONS | 0.00% | 29.77K | Mar 09 - Mar 10 | View |
| Mar 08, 2021 | Steinar J Engelsen | — | 2.71K | $36.90 | $100.00K | BUY | 0.91% | 299.01K | Mar 04 | View |
| Feb 10, 2021 | Christine Pellizzari | CHIEF LEGAL OFFICER | 0.00 | $27.77 | -$729.21K | SELL-OPTIONS | 0.00% | 140.72K | Feb 08 - Feb 09 | View |
| Jan 27, 2021 | Christine Pellizzari | CHIEF LEGAL OFFICER | 0.00 | $27.07 | -$765.73K | SELL-OPTIONS | 0.00% | 140.72K | Jan 25 - Jan 26 | View |
| Jan 22, 2021 | Christine Pellizzari | CHIEF LEGAL OFFICER | 0.00 | $25.91 | -$903.50K | SELL-OPTIONS | 0.00% | 140.72K | Jan 20 - Jan 21 | View |
| Dec 23, 2020 | William Lewis | CHAIR&CHIEF EXECUTIVE OFFICER | 0.00 | $19.99 | -$1.66M | SELL-OPTIONS | 0.00% | 164.79K | Dec 22 | View |
| Dec 09, 2020 | Alfred Altomari | — | -20.00K | $39.57 | -$791.40K | SELL | -48.85% | 20.94K | Dec 07 | View |
| Nov 24, 2020 | Melvin Sharoky M.D, | — | -8.00K | $39.05 | -$312.36K | SELL | -3.22% | 240.60K | Nov 20 - Nov 23 | View |
| Nov 20, 2020 | Melvin Sharoky M.D, | — | -4.00K | $39.48 | -$157.92K | SELL | -18.51% | 17.61K | Nov 19 | View |
| Nov 06, 2020 | William Lewis | — | 28.64K | $19.39 | -$5.79M | TAX | 21.04% | 164.79K | May 15 - Nov 06 | View |
| Nov 05, 2020 | Christine Pellizzari | — | 38.08K | $22.19 | -$2.65M | TAX | 39.70% | 134.00K | May 15 - Nov 05 | View |
| Sep 16, 2020 | Melvin Sharoky M.D, | — | -20.00K | $30.68 | -$613.57K | SELL | -7.45% | 248.60K | Sep 14 - Sep 15 | View |
| Aug 13, 2020 | S. Nicole Schaeffer | — | -1.13K | $19.27 | -$191.17K | TAX | -3.10% | 35.23K | May 15 - Aug 12 | View |
| Aug 12, 2020 | John Soriano | — | -994.00 | $22.05 | -$877.82K | TAX | -3.79% | 25.21K | May 15 - Aug 10 | View |
| Nov 20, 2019 | John Goll | CHIEF ACCOUNTING OFFICER | 0.00 | $16.31 | -$186.50K | SELL-OPTIONS | 0.00% | 7.32K | Nov 18 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.